Respreeza - direct healthcare professional communication (DHPC)

Human alpha1-proteinase inhibitor

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Respreeza (human alpha-1-proteinase inhibitor): Sterility issue with the infusion device co-packed with Respreeza 4.000 mg and 5.000 mg

Key facts

• Medicine name:
  Respreeza
• Active substance:
  Human alpha1-proteinase inhibitor
• Therapeutic area (MeSH):
  • Genetic Diseases, Inborn
  • Lung Diseases
• Procedure number:
  EMEA/H/C/002739
• DHPC type:
  Medicine shortage
• Human ATC codes:
  B02AB02
• Dissemination date:
  26/03/2021